IBM Watson has identified therapies for 323 cancer patients that went overlooked by a molecular tumor board. Researchers said next-generation genomic sequencing is "evolving too rapidly to rely solely on human curation" when it comes to targeting treatments.

See the source article by following the link below:
IBM Watson has identified therapies for 323 cancer patients that went overlooked by a molecular tumor board. Researchers said next-generation genomic sequencing is "evolving too rapidly to rely solely on human curation" when it comes to targeting treatments.